These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 15151033)
1. [Subpectoral implantable cardioverter defibrillator implantation in a 20 kg-weighted child]. Usui M; Takagi Y; Masumoto H; Ueda Y Kyobu Geka; 2004 May; 57(5):364-6. PubMed ID: 15151033 [TBL] [Abstract][Full Text] [Related]
2. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years. Kleemann T; Becker T; Doenges K; Vater M; Senges J; Schneider S; Saggau W; Weisse U; Seidl K Circulation; 2007 May; 115(19):2474-80. PubMed ID: 17470696 [TBL] [Abstract][Full Text] [Related]
3. Transvenous pectoral implantation of single lead implantable cardioverter defibrillator. Wang F; Hua W; Chen X Chin Med J (Engl); 1999 Jan; 112(1):22-4. PubMed ID: 11593633 [TBL] [Abstract][Full Text] [Related]
4. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations). Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697 [TBL] [Abstract][Full Text] [Related]
5. Implantable cardioverter-defibrillators in patients with hypertrophic cardiomyopathy -- dilemmas and difficulties. Przybylski A; Małecka L; Pytkowski M; Chojnowska L; Lewandowski M; Sterliński M; Maciag A; Ruzyłło W; Szwed H Kardiol Pol; 2005 Oct; 63(4):391-7; discussion 398. PubMed ID: 16273479 [TBL] [Abstract][Full Text] [Related]
12. [Sub-pectoral implantation of defibrillators: intraoperative data and long-term outcome]. Hief C; Podczeck A; Frohner K; Nürnberg M; Veit F; Steinbach K Wien Klin Wochenschr; 1998 Jul; 110(13-14):491-5. PubMed ID: 9746963 [TBL] [Abstract][Full Text] [Related]
13. [The pectoral implant of an automatic defibrillator by cardiologists in an electrophysiology laboratory]. Marín-Huerta E; Moro Serrano C; Novo L; Madrid AH; Lage J; Mestre JL; Vargas C; Yepes L; Aguilera A Rev Esp Cardiol; 1994 Oct; 47(10):706-9. PubMed ID: 7991926 [TBL] [Abstract][Full Text] [Related]
14. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy. Lin G; Nishimura RA; Gersh BJ; Phil D; Ommen SR; Ackerman MJ; Brady PA Heart; 2009 May; 95(9):709-14. PubMed ID: 19282314 [TBL] [Abstract][Full Text] [Related]
15. Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study. Koller MT; Schaer B; Wolbers M; Sticherling C; Bucher HC; Osswald S Circulation; 2008 Apr; 117(15):1918-26. PubMed ID: 18391108 [TBL] [Abstract][Full Text] [Related]
16. [Estimation of defibrillation threshold using abdominally implanted cardioverter-defibrillator with an additional defibrillation pole in a dual-coil lead endocardial defibrillation system]. Pazdyga A; Lubiński A; Lewicka-Nowak E; Królak T; Kempa M; Zienciuk A; Raczak G Pol Merkur Lekarski; 2007 Feb; 22(128):86-9. PubMed ID: 17598649 [TBL] [Abstract][Full Text] [Related]
17. Dual-coil vs single-coil active pectoral implantable defibrillator lead systems: defibrillation energy requirements and probability of defibrillation success at multiples of the defibrillation energy requirements. Schulte B; Sperzel J; Carlsson J; Schwarz T; Ehrlich W; Pitschner HF; Neuzner J Europace; 2001 Jul; 3(3):177-80. PubMed ID: 11467457 [TBL] [Abstract][Full Text] [Related]
18. [Massive myocardial hypertrophy in hypertrophic cardiomyopathy: a risk factor for sudden death and high defibrillation threshold during cardioverter-defibrillator implantation]. Jastrzebski M; Czarnecka D; Bacior B; Petkow-Dimitrow P; Wilczek R; Kawecka-Jaszcz K Kardiol Pol; 2005 Aug; 63(2):191-5; discussion 196. PubMed ID: 16136416 [TBL] [Abstract][Full Text] [Related]
20. High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator. Korte T; Köditz H; Niehaus M; Paul T; Tebbenjohanns J Pacing Clin Electrophysiol; 2004 Jul; 27(7):924-32. PubMed ID: 15271011 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]